Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

Ned Calonge, Diana B. Petitti, Thomas G. DeWitt, Leon Gordis, Kimberly D. Gregory, Russell Harris, George Isham, Michael L. LeFevre, Carol Loveland-Cherry, Lucy N. Marion, Virginia A. Moyer, Judith K. Ockene, George F. Sawaya, Albert L. Siu, Steven M. Teutsch, Barbara P. Yawn

Research output: Contribution to journalArticle

468 Citations (Scopus)

Abstract

Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation about the use of aspirin for the prevention of coronary heart disease. Methods: Review of the literature since 2002, focusing on new evidence on the benefits and harms of aspirin for the primary prevention of cardiovascular disease, including myocardial infarction and stroke. The new evidence was reviewed and synthesized according to sex. Recommendations: Encourage men age 45 to 79 years to use aspirin when the potential benefit of a reduction in myocardial infarctions outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Encourage women age 55 to 79 years to use aspirin when the potential benefit of a reduction in ischemic strokes outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Evidence is insufficient to assess the balance of benefits and harms of aspirin for cardiovascular disease prevention in men and women 80 years or older. (I statement) Do not encourage aspirin use for cardiovascular disease prevention in women younger than 55 years and in men younger than 45 years. (D recommendation).

Original languageEnglish (US)
Pages (from-to)396-404
Number of pages9
JournalAnnals of internal medicine
Volume150
Issue number6
DOIs
StatePublished - Mar 17 2009
Externally publishedYes

Fingerprint

Advisory Committees
Aspirin
Cardiovascular Diseases
Gastrointestinal Hemorrhage
Stroke
Myocardial Infarction
Primary Prevention
Coronary Disease

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Aspirin for the Prevention of Cardiovascular Disease : U.S. Preventive Services Task Force Recommendation Statement. / Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Gordis, Leon; Gregory, Kimberly D.; Harris, Russell; Isham, George; LeFevre, Michael L.; Loveland-Cherry, Carol; Marion, Lucy N.; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Siu, Albert L.; Teutsch, Steven M.; Yawn, Barbara P.

In: Annals of internal medicine, Vol. 150, No. 6, 17.03.2009, p. 396-404.

Research output: Contribution to journalArticle

Calonge, N, Petitti, DB, DeWitt, TG, Gordis, L, Gregory, KD, Harris, R, Isham, G, LeFevre, ML, Loveland-Cherry, C, Marion, LN, Moyer, VA, Ockene, JK, Sawaya, GF, Siu, AL, Teutsch, SM & Yawn, BP 2009, 'Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement', Annals of internal medicine, vol. 150, no. 6, pp. 396-404. https://doi.org/10.7326/0003-4819-150-6-200903170-00008
Calonge, Ned ; Petitti, Diana B. ; DeWitt, Thomas G. ; Gordis, Leon ; Gregory, Kimberly D. ; Harris, Russell ; Isham, George ; LeFevre, Michael L. ; Loveland-Cherry, Carol ; Marion, Lucy N. ; Moyer, Virginia A. ; Ockene, Judith K. ; Sawaya, George F. ; Siu, Albert L. ; Teutsch, Steven M. ; Yawn, Barbara P. / Aspirin for the Prevention of Cardiovascular Disease : U.S. Preventive Services Task Force Recommendation Statement. In: Annals of internal medicine. 2009 ; Vol. 150, No. 6. pp. 396-404.
@article{ddc0b9e3a419409485b2023fcb37b915,
title = "Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement",
abstract = "Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation about the use of aspirin for the prevention of coronary heart disease. Methods: Review of the literature since 2002, focusing on new evidence on the benefits and harms of aspirin for the primary prevention of cardiovascular disease, including myocardial infarction and stroke. The new evidence was reviewed and synthesized according to sex. Recommendations: Encourage men age 45 to 79 years to use aspirin when the potential benefit of a reduction in myocardial infarctions outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Encourage women age 55 to 79 years to use aspirin when the potential benefit of a reduction in ischemic strokes outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Evidence is insufficient to assess the balance of benefits and harms of aspirin for cardiovascular disease prevention in men and women 80 years or older. (I statement) Do not encourage aspirin use for cardiovascular disease prevention in women younger than 55 years and in men younger than 45 years. (D recommendation).",
author = "Ned Calonge and Petitti, {Diana B.} and DeWitt, {Thomas G.} and Leon Gordis and Gregory, {Kimberly D.} and Russell Harris and George Isham and LeFevre, {Michael L.} and Carol Loveland-Cherry and Marion, {Lucy N.} and Moyer, {Virginia A.} and Ockene, {Judith K.} and Sawaya, {George F.} and Siu, {Albert L.} and Teutsch, {Steven M.} and Yawn, {Barbara P.}",
year = "2009",
month = "3",
day = "17",
doi = "10.7326/0003-4819-150-6-200903170-00008",
language = "English (US)",
volume = "150",
pages = "396--404",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "6",

}

TY - JOUR

T1 - Aspirin for the Prevention of Cardiovascular Disease

T2 - U.S. Preventive Services Task Force Recommendation Statement

AU - Calonge, Ned

AU - Petitti, Diana B.

AU - DeWitt, Thomas G.

AU - Gordis, Leon

AU - Gregory, Kimberly D.

AU - Harris, Russell

AU - Isham, George

AU - LeFevre, Michael L.

AU - Loveland-Cherry, Carol

AU - Marion, Lucy N.

AU - Moyer, Virginia A.

AU - Ockene, Judith K.

AU - Sawaya, George F.

AU - Siu, Albert L.

AU - Teutsch, Steven M.

AU - Yawn, Barbara P.

PY - 2009/3/17

Y1 - 2009/3/17

N2 - Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation about the use of aspirin for the prevention of coronary heart disease. Methods: Review of the literature since 2002, focusing on new evidence on the benefits and harms of aspirin for the primary prevention of cardiovascular disease, including myocardial infarction and stroke. The new evidence was reviewed and synthesized according to sex. Recommendations: Encourage men age 45 to 79 years to use aspirin when the potential benefit of a reduction in myocardial infarctions outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Encourage women age 55 to 79 years to use aspirin when the potential benefit of a reduction in ischemic strokes outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Evidence is insufficient to assess the balance of benefits and harms of aspirin for cardiovascular disease prevention in men and women 80 years or older. (I statement) Do not encourage aspirin use for cardiovascular disease prevention in women younger than 55 years and in men younger than 45 years. (D recommendation).

AB - Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation about the use of aspirin for the prevention of coronary heart disease. Methods: Review of the literature since 2002, focusing on new evidence on the benefits and harms of aspirin for the primary prevention of cardiovascular disease, including myocardial infarction and stroke. The new evidence was reviewed and synthesized according to sex. Recommendations: Encourage men age 45 to 79 years to use aspirin when the potential benefit of a reduction in myocardial infarctions outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Encourage women age 55 to 79 years to use aspirin when the potential benefit of a reduction in ischemic strokes outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Evidence is insufficient to assess the balance of benefits and harms of aspirin for cardiovascular disease prevention in men and women 80 years or older. (I statement) Do not encourage aspirin use for cardiovascular disease prevention in women younger than 55 years and in men younger than 45 years. (D recommendation).

UR - http://www.scopus.com/inward/record.url?scp=63849141400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63849141400&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-150-6-200903170-00008

DO - 10.7326/0003-4819-150-6-200903170-00008

M3 - Article

C2 - 19293068

AN - SCOPUS:63849141400

VL - 150

SP - 396

EP - 404

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 6

ER -